Practical Guidance for Clinical Microbiology Laboratories: Microbiologic diagnosis of implant-associated infections

Marisa Ann Azad1,2, Robin Patel3,4

  • 1Division of Infectious Diseases, Department of Medicine, The Ottawa Hospital, Ottawa, Canada.

PubMed

Insights

Diagnosing implant-associated infections (IAIs) is challenging due to biofilms and unclear microbial significance. This review explores microbiologic diagnostic approaches for IAIs, including molecular assays.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biomedical Engineering

Background:

  • Implant-associated infections (IAIs) present significant patient morbidity and mortality risks.
  • Biofilm formation on devices complicates IAI diagnosis and treatment.
  • Accurate microbial identification is crucial for effective IAI management.

Purpose of the Study:

  • To review the challenges in diagnosing implant-associated infections (IAIs).
  • To present microbiologic diagnostic strategies for IAIs.
  • To highlight the role of molecular assays in IAI diagnosis.

Main Methods:

  • Review of current literature on IAI diagnostics.
  • Analysis of traditional culture-based methods and their limitations.
  • Evaluation of molecular diagnostic techniques, including nucleic acid amplification tests and next-generation sequencing.

Main Results:

  • Standard microbial cultures show variable sensitivity for IAI diagnosis.
  • Culture-negative IAIs remain a significant diagnostic hurdle.
  • Molecular assays offer promising alternatives for detecting microorganisms in IAIs.

Conclusions:

  • Accurate diagnosis of IAIs is paramount for successful patient outcomes.
  • Molecular diagnostics are increasingly important for overcoming challenges in IAI detection.
  • Further research into optimized diagnostic approaches for IAIs is warranted.